Methinks has today announced the signing of a collaboration agreement with Siemens Healthineers to bring innovative digital solutions for stroke management to markets in southern Europe.
The two companies jointly announced this venture at the opening of the new ‘Centre for the Adoption of AI [artificial intelligence] in Healthcare’ held in Madrid, Spain—Siemens Healthineers’ first hub in the region that will not only “drive the digital transformation of healthcare” across Greece, Italy, Portugal and Spain, but will also support hospitals, professionals and healthcare institutions in adopting AI on a large scale, as outlined in a press release.
Siemens Healthineers’ focus is on supporting stroke management through cutting-edge diagnostic equipment and digital tools to improve stroke diagnosis, and reduce time to treatment, while Methinks’ advanced innovations on non-contrast AI modules alongside its Microsoft Teams-based communication platform complement this offering by expanding clinical capabilities to early assessment and network coordination.
The two companies have integrated the syngo.via neuro package platform (Siemens Healthineers), and the Methinks coordination platform and AI algorithms, creating “a comprehensive solution for all hospitals in southern Europe and potentially beyond”. Together, the companies are already collaborating in commercial opportunities across southern Europe and will continue to explore joint go-to-market activities, comarketing initiatives, and clinical validation projects—firstly in Europe but also across the globe.
“Our vision is to enable life-saving stroke treatments worldwide,” said Pau Rodríguez, chief executive officer (CEO) of Methinks. “With Siemens, we have not only built an advanced AI and comprehensive platform in Microsoft Teams, but are also working jointly on go-to-market opportunities. Partnering is crucial to scaling stroke care, and having the chance to work with Siemens in this endeavour is a privilege.”
“We in Siemens Healthineers are committed to working and investing in bringing solutions capable of reducing mortality and disability caused by stroke,” added David Labajo, head of Digital and Automation Southern Europe (SEU) at Siemens Healthineers. “Care coordination platforms, together with the power of AI, can make a big difference for all. In this regard, Methinks’ AI complements our digital stroke portfolio extremely well and, together, we are building a scalable solution that meets our customers’ needs. This collaboration represents Siemens Healthineers’ belief that innovation without adoption is just theory. Therefore, our joint focus goes beyond technology development; it is strategically aimed at ensuring successful integration into clinical practice, which is the core mission of our new ‘Centre for the Adoption of AI in Healthcare’.”
Methinks notes in its release that this announcement follows the US Food and Drug Administration (FDA) clearance of the company’s AI solution—and a strategic distribution agreement with Medtronic in Central Europe, the Middle East, and Africa—further underscoring its “commitment to expanding access to stroke treatments globally”.
